Global and China Cancer Gene Therapy Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Cancer Gene Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • BioCancell

    • OncoGenex Pharmaceuticals

    • Shanghai Sunway Biotech

    • GlaxoSmithKline

    • SynerGene Therapeutics

    • Merck

    • Bluebird bio, Inc

    • Adaptimmune

    • Celgene

    • Shenzhen SiBiono GeneTech

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Ex-vivo

    • In-vivo

    Application:

    • Biopharma Companies

    • Research Institutes

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Cancer Gene Therapy Industry Overview

      • 1.1.1 Cancer Gene Therapy Market Scope and Market Segments

      • 1.1.2 Cancer Gene Therapy Industry Characteristics

      • 1.1.3 Global and China Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Cancer Gene Therapy Production Value and Growth Rate (2017-2028)

    • 1.2 Global Cancer Gene Therapy Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Ex-vivo

      • 1.2.2 In-vivo

    • 1.3 Global Cancer Gene Therapy Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Biopharma Companies

      • 1.3.2 Research Institutes

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Cancer Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Cancer Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Cancer Gene Therapy Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Cancer Gene Therapy Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Cancer Gene Therapy Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Cancer Gene Therapy Industry Porter's Five Forces Model Analysis

      • 2.2.3 Cancer Gene Therapy Industry PEST Analysis

    • 2.3 Cancer Gene Therapy Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Cancer Gene Therapy Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Cancer Gene Therapy Industry

    Chapter 3 Global and China Cancer Gene Therapy Market, by Manufacturer

    • 3.1 Global and China Cancer Gene Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Cancer Gene Therapy Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Cancer Gene Therapy Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Cancer Gene Therapy Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Cancer Gene Therapy Market Top 3 Players

    Chapter 4 Global and China Cancer Gene Therapy Market, by Type (2017-2028)

    • 4.1 Cancer Gene Therapy Market Trend, by Type

    • 4.2 Global Cancer Gene Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Cancer Gene Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Cancer Gene Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Cancer Gene Therapy Price Trend, by Type (2017-2028)

    • 4.3 China Cancer Gene Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Cancer Gene Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Cancer Gene Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Cancer Gene Therapy Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Cancer Gene Therapy Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Cancer Gene Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Cancer Gene Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Cancer Gene Therapy Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Cancer Gene Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Cancer Gene Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Cancer Gene Therapy Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Cancer Gene Therapy Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Cancer Gene Therapy Market Analysis

    • 7.1 North America Cancer Gene Therapy Market, by Type

    • 7.2 North America Cancer Gene Therapy Market, by Application

    • 7.3 North America Cancer Gene Therapy Market Analysis and Forecast, by Country

      • 7.3.1 United States Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Cancer Gene Therapy Market Analysis

    • 8.1 Europe Cancer Gene Therapy Market, by Type

    • 8.2 Europe Cancer Gene Therapy Market, by Application

    • 8.3 Europe Cancer Gene Therapy Market Analysis and Forecast, by Country

      • 8.3.1 Germany Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Cancer Gene Therapy Market Analysis

    • 9.1 APAC Cancer Gene Therapy Market, by Type

    • 9.2 APAC Cancer Gene Therapy Market, by Application

    • 9.3 APAC Cancer Gene Therapy Market Analysis and Forecast, by Country

      • 9.3.1 China Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Cancer Gene Therapy Market Analysis

    • 10.1 Latin America, Middle East and Africa Cancer Gene Therapy Market, by Type

    • 10.2 Latin America, Middle East and Africa Cancer Gene Therapy Market, by Application

    • 10.3 Latin America, Middle East and Africa Cancer Gene Therapy Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Cancer Gene Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Cancer Gene Therapy Company Profiles

      • 11.1 BioCancell

        • 11.1.1 BioCancell Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 BioCancell Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.1.3 BioCancell Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 OncoGenex Pharmaceuticals

        • 11.2.1 OncoGenex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.2.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Shanghai Sunway Biotech

        • 11.3.1 Shanghai Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.3.3 Shanghai Sunway Biotech Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline

        • 11.4.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 SynerGene Therapeutics

        • 11.5.1 SynerGene Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 SynerGene Therapeutics Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.5.3 SynerGene Therapeutics Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Merck

        • 11.6.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Merck Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.6.3 Merck Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bluebird bio, Inc

        • 11.7.1 Bluebird bio, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bluebird bio, Inc Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.7.3 Bluebird bio, Inc Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Adaptimmune

        • 11.8.1 Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Adaptimmune Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.8.3 Adaptimmune Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Celgene

        • 11.9.1 Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Celgene Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.9.3 Celgene Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Shenzhen SiBiono GeneTech

        • 11.10.1 Shenzhen SiBiono GeneTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Profiles, Application and Specification

        • 11.10.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Cancer Gene Therapy Industry Investment Prospect and Risk Assessment

    • 12.1 Cancer Gene Therapy Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Cancer Gene Therapy Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Global Cancer Gene Therapy Production Value and Growth Rate (2017-2028)

    • Figure China Cancer Gene Therapy Production Value and Growth Rate (2017-2028)

    • Figure Global Cancer Gene Therapy Market Size and Growth Rate of Ex-vivo (2017-2028)

    • Figure Global Cancer Gene Therapy Market Size and Growth Rate of In-vivo (2017-2028)

    • Figure Global Cancer Gene Therapy Market Size and Growth Rate of Biopharma Companies (2017-2028)

    • Figure Global Cancer Gene Therapy Market Size and Growth Rate of Research Institutes (2017-2028)

    • Figure Global Cancer Gene Therapy Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Cancer Gene Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Cancer Gene Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Cancer Gene Therapy Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Cancer Gene Therapy Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Cancer Gene Therapy Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Cancer Gene Therapy Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Cancer Gene Therapy Market Share, by Manufacturer in 2021

    • Figure Global and China Cancer Gene Therapy Market Share, by Manufacturer in 2022

    • Table Global Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table Global Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Global Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table Global Cancer Gene Therapy Sales Value, by Type (2017-2028)

    • Table Global Cancer Gene Therapy Sales Value Share, by Type (2017-2028)

    • Figure Global Cancer Gene Therapy Price Trend, by Type (2017-2028)

    • Table China Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table China Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure China Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table China Cancer Gene Therapy Sales Value, by Type (2017-2028)

    • Table China Cancer Gene Therapy Sales Value Share, by Type (2017-2028)

    • Figure China Cancer Gene Therapy Price Trend, by Type (2017-2028)

    • Table Global Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table Global Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Global Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Table Global Cancer Gene Therapy Sales Value, by Application (2017-2028)

    • Table Global Cancer Gene Therapy Sales Value Share, by Application (2017-2028)

    • Figure Global Cancer Gene Therapy Sales Value Share, by Application (2017-2028)

    • Table China Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table China Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Table China Cancer Gene Therapy Sales Value, by Application (2017-2028)

    • Table China Cancer Gene Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Cancer Gene Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure North America Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Cancer Gene Therapy Production, Import, Consumption and Export (2017-2022)

    • Table North America Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table North America Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure North America Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table North America Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table North America Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure North America Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure United States Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure United States Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Canada Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Table Europe Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table Europe Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Europe Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table Europe Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table Europe Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Europe Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Germany Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure UK Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure UK Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure France Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure France Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Italy Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Spain Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Poland Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Russia Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Table APAC Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table APAC Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure APAC Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table APAC Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table APAC Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure APAC Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Japan Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure India Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure India Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Cancer Gene Therapy Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Cancer Gene Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Cancer Gene Therapy Sales Value and Growth Rate (2017-2028)

    • Table BioCancell Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioCancell Product Profiles, Application and Specification

    • Table BioCancell Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table OncoGenex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table OncoGenex Pharmaceuticals Product Profiles, Application and Specification

    • Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai Sunway Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai Sunway Biotech Product Profiles, Application and Specification

    • Table Shanghai Sunway Biotech Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SynerGene Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SynerGene Therapeutics Product Profiles, Application and Specification

    • Table SynerGene Therapeutics Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bluebird bio, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bluebird bio, Inc Product Profiles, Application and Specification

    • Table Bluebird bio, Inc Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Adaptimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Adaptimmune Product Profiles, Application and Specification

    • Table Adaptimmune Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Product Profiles, Application and Specification

    • Table Celgene Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shenzhen SiBiono GeneTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shenzhen SiBiono GeneTech Product Profiles, Application and Specification

    • Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.